WALTHAM, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced that it has entered into an agreement to...
If Murchinson Wins, They Would Control 100% of The Board The Upcoming Extraordinary General Meeting Is Not A Vote On Any Strategic Transaction
WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) and Infinite Epigenetics ™ (“Infinite Epigenetics,”...
Believes the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That...
Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value Creation Proposed...
Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, “Murchinson” or “we”), a significant shareholder with approximately 7.4% of the outstanding shares of...
WALTHAM, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano” or the “Company”) today issued the following letter to shareholders from Chief...
Accelerating Progress Toward Unlocking and Maximizing Long-Term Shareholder Value Transaction Expected to Reduce Annualized Cash Burn by Approximately $15 Million WALTHAM, Mass., May 27, 2026...
It Is Time to Talk About Nano Dimension
Comments on Amended Schedule 13D Filing by Murchinson Strategic Alternatives Review Process Progresses WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) today...